Authors Reply to Readers’ Questions about Ivermectin Use in COVID-19 Prophylaxis
Researcher Name
Prof. Abdelmonem Awad Hegazy
Name Of Journal
Journal of Clinical and Diagnostic Research
Volume No.
; 15(10): OL01
Date Of Publication
2021.10
Abstract
Our clinical trial research entitled “Use of Ivermectin as a Potential Chemoprophylaxis for COVID-19 in Egypt: A Randomized Clinical Trial” was recently published in the Journal of Clinical and Diagnostic
Research [1]. According to readers’ questions sent to the journal, we would like to clarify their points.
